Staphylococcus aureus is the Predominant Pathogen in Hospitalised Patients with Diabetes-Related Foot Infections: An Australian Perspective

Kate E. Morton,Sarah H. Coghill
DOI: https://doi.org/10.3390/antibiotics13070594
2024-06-27
Antibiotics
Abstract:Diabetes prevalence continues to increase worldwide, which has led to a rising incidence of diabetes-related foot infections (DFIs). There is significant local variation in the microbiology of DFIs, and Pseudomonas spp. is suggested to be more prevalent in subtropical climates. The aim of this study was to investigate the local microbiological findings in patients admitted to the hospital with DFIs. This retrospective study analysed data from all adult patients diagnosed with diabetes and admitted to the hospital for the treatment of a DFI between 1 January 2021 and 31 December 2022. Both superficial wound swabs and tissue cultures were included. The Infectious Diseases Society of America classification system was used to categorise the severity of the DFI. Patient characteristics and demographics were analysed using descriptive statistics. One hundred fifty-one episodes of care were included. Most of the DFIs were classified as moderate infections 101/151 (67%). The most commonly isolated microorganism was Staphylococcus aureus (33%) followed by normal skin flora (11%) and β-haemolytic streptococci (7%). P. aeruginosa was isolated more commonly in those with chronic DFIs (10%) compared to those with acute DFIs (2%). Despite the frequent identification of S. aureus, 83% of patients received an antipseudomonal antibiotic. The introduction of multidisciplinary DFI rounds should be considered.
pharmacology & pharmacy,infectious diseases
What problem does this paper attempt to address?
This paper aims to investigate the pathogenic microbiology of diabetic foot infection (DFI) in a regional medical center in Australia, particularly in a subtropical climate. The study retrospectively analyzed 151 cases of DFI requiring hospitalization from January 2021 to December 2022, involving 107 patients. The main findings include: - Staphylococcus aureus (S. aureus) is the most common pathogenic microorganism, regardless of the severity of the infection or whether it is an acute or chronic infection. This is consistent with previous research findings. - Only 10% of S. aureus samples in the study were methicillin-resistant, which is lower than the reported data in the literature. This suggests that routine empirical treatment for MRSA may not be necessary for DFI treatment locally. - The proportion of DFI caused by Pseudomonas aeruginosa (P. aeruginosa) is similar to high-income countries like the UK and Italy, approximately 10%. However, it is much lower than the proportion in low-income countries (14.11% to 20.1%). Although the study location is in a subtropical climate, DFI caused by P. aeruginosa is not more prevalent. - In severe DFI cases, 81% of identified microorganisms are Gram-positive bacteria. Interestingly, P. aeruginosa was only found in one subgroup of severe DFI, along with multiple infections of Group A Streptococcus and MRSA. - Microbiological characteristics of DFI in flooded environments are different, as Acinetobacter baumannii and Aeromonas hydrophila were only identified in flooded DFI cases. This highlights the importance of following best practice guidelines when empirically selecting antibiotics for such patient populations. - The study found that the majority of DFI patients (83%) received antibiotics targeting P. aeruginosa, although this broad-spectrum regimen is not necessary according to microbiological results. Only 18% of DFI cases were classified as severe infections, and non-life-threatening infections typically do not require initial use of broad-spectrum antibiotics. - The study suggests that local antimicrobial stewardship programs should focus on reducing the inappropriate use of antibiotics such as piperacillin/tazobactam, as excessive antibiotic use can lead to increased costs and adverse clinical events. The conclusion of the paper is that Staphylococcus aureus is the main pathogen regardless of the severity of DFI. Although DFI caused by P. aeruginosa is rare, a significant number of patients still receive empirical antibiotics targeting P. aeruginosa. It is necessary to align local practices with national and international best practice guidelines to improve DFI management. Optimizing DFI management requires efforts in improving diagnosis, interdisciplinary collaboration, and antimicrobial stewardship.